AKRO AKERO THERAPEUTICS INC

Ownership history in Squarepoint Ops LLC  ·  15 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in AKERO THERAPEUTICS INC (AKRO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2020 Q1)
Avg. % of fund
0.0%
First filed
2019 Q3
Last filed
2025 Q3
Quarters held
15
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 121,477 +96,030 +377.4% 0.01% $5.8M
2025 Q2 ADDED 25,447 +14,447 +131.3% 0.00% $1.4M
2025 Q1 REDUCED 11,000 -29,661 -72.9% 0.00% $445K
2025 Q1 ADDED 40,661 +32,664 +408.5% 0.00% $1.6M
2024 Q1 REDUCED 7,997 -67,152 -89.4% 0.00% $202K
2023 Q4 ADDED 75,149 +39,558 +111.1% 0.00% $1.8M
2023 Q3 ADDED 35,591 +15,500 +77.1% 0.00% $1.8M
2023 Q1 REDUCED 20,091 -6,945 -25.7% 0.00% $769K
2022 Q4 REDUCED 27,036 -12,779 -32.1% 0.01% $1.5M
2020 Q4 ADDED 39,815 +29,830 +298.7% 0.01% $1.0M
5 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)

Other funds also holding AKRO

As of 2025 Q4 — sorted by position size

Nebula Research & Development LLC 0.07% IFP Advisors, Inc 3Y 7Y 0.0%
← Back to Squarepoint Ops LLC Holdings